In vitro and in vivo synergistic effects of cryptdin 2 and ampicillin against Salmonella

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 9, 2011, Pages 4176-4182

  Rishi, Praveen ^a   Preet, Simran ^a   Bharrhan, Sushma ^a   Verma, Indu ^b  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CRYPTDIN 2; POLYPEPTIDE ANTIBIOTIC AGENT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG POTENTIATION; EX VIVO STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; LIVER; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PANETH CELL; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SMALL INTESTINE; SPLEEN;

AMPICILLIN; ANIMALS; ANTI-INFECTIVE AGENTS; FEMALE; MALE; MICE; MICROBIAL SENSITIVITY TESTS; PROTEINS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 80051818566     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00273-11     Document Type: Article

References (43)

1. Aarestrup, F M, et al. 2001. Effect of abolishment of the use of antimicrobial agents for growth promoters on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob. Agents Chemother. 45:2054-2059. (Pubitemid 32591697)
2. Arnett, E., R I Lehrer, P. Pratikhya, W. Lu, and S. Seveau. 2011. Defensins enable macrophages to inhibit the intracellular proliferation of Listeria monocytogenes. Cell. Microbiol. [Epub ahead of print.] doi:10.1111/j.1462-5822.2010.01563.x.
3. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907-916. (Pubitemid 32976162)
4. Bowdish, D M E, et al. 2005. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77:451-459. (Pubitemid 40489520)
5. Chanana, V., P. Ray, D B Rishi, and P. Rishi. 2007. Reactive nitrogen intermediates and monokines induce caspase-3 mediated macrophage apoptosis by anaerobically stressed Salmonella typhi. Clin. Exp. Immunol. 150:368-374. (Pubitemid 47609576)
6. Chang, H R, I-R Vladoianu, and J-C Pechere. 1990. Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages. J. Antimicrob. Chemother. 26:689-694.
7. Darveau, R P, et al. 1991. Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob. Agents Chemother. 35:1153-1159.
8. Eisenhauer, P B, S S S L Harwig, and R I Lehrer. 1992. Cryptdins: Antimicrobial defensins of the murine small intestine. Infect. Immun. 60:3556-3565.
9. Foureau, D M, et al. 2010. TLR9-dependent induction of intestinal alpha-defensins by Toxoplasma gondii. J. Immunol. 184:7022-7029.
10. Giacometti, A., O. Cirioni, F. Barchiesi, M. Fortuna, and G. Scalise. 1999. In vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. J. Antimicrob. Chemother. 44:641-645. (Pubitemid 29532842)
11. Green, L C, et al. 1982. Analysis of nitrate, nitrite and 15N nitrate in biological fluids. Anal. Biochem. 126:131-138. (Pubitemid 13203451)
12. Hancock, R E W, and H-G Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557. (Pubitemid 44967479)
13. Ibezim, E C, et al. 2006. A study of the in-vitro interaction of co-trimoxazole and ampicillin using the checker board method. Afr. J. Biotechnol. 5:1284-1288. (Pubitemid 44049602)
14. Inoue, R., et al. 2008. Postnatal changes in the expression of genes for cryptdins 1-6 and the role of luminal bacteria in cryptdin gene expression in mouse small intestine. FEMS Immunol. Med. Microbiol. 52:407-416. (Pubitemid 351420759)
15. Izumiya, H., et al. 2011. Whole-genome analysis of Salmonella enterica serovar Typhimurium T000240 reveals the acquisition of a genomic island involved in multidrug resistance via IS1 derivatives on the chromosome. Antimicrob. Agents Chemother. 55:623-630.
16. Kalita, A., I. Verma, and G K Khuller. 2004. Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy. J. Infect. Dis. 190:1476-1480. (Pubitemid 39332188)
17. Kono, Y. 1978. Generation of superoxide radical during autooxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 186:189-195. (Pubitemid 8290500)
18. Labro, M T 2000. Interference of antibacterial agents with phagocyte functions: Immunomodulation or immuno-fairy tales. Clin. Microbiol. Rev. 13:615-650.
19. Lencer, W I, et al. 1997. Induction of epithelial chloride secretion by channel-forming cryptdins 2 and 3. Proc. Natl. Acad. Sci. U. S. A. 94:8585-8589. (Pubitemid 27335082)
20. Lowry, O H, N J Rosenbrough, A L Farr, and R J Randell. 1951. Protein measurement with Folin's phenol reagent. J. Biol. Chem. 193:265-275.
21. Luders, T., G A Berkemo, G. Finland, J. Nissen-Meyer, and I F Nes. 2003. Strong synergy between a eukaryotic antimicrobial peptide and bacteriocins from lactic acid bacteria. Appl. Environ. Microbiol. 69:1797-1799. (Pubitemid 36314323)
22. Mastroianni, J R, and A J Ouellette. 2009. α-Defensins in enteric innate immunity: Functional Paneth cell α-defensins in mouse colonic lumen. J. Biol. Chem. 284:27848-27856.
23. Masuda, K., N. Sakai, K. Nakamura, S. Yoshioka, and T. Ayabe. 2010. Bactericidal activity of mouse α-defensin cryptdin-4 predominantly affects noncommensal bacteria. J. Innate Immun. [Epub ahead of print.] doi: 10.1159/000322037.
24. McEwen, S A, and P J Fedorka-Cray. 2002. Antimicrobial use and resistance in animals. Clin. Infect. Dis. 34:S93-S106. (Pubitemid 34553688)
25. Moncada, S., R M Palmer, and E A Higgs. 1991. Nitric oxide: Physiology, patho-physiology and pharmacology. Pharmacol. Rev. 43:109.
26. Nikaido, E., A. Yamaguchi, and K. Nishino. 2008. AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J. Biol. Chem. 283:24245-24253.
27. Piddock, L J V, D G White, K. Gensberg, I. Pumbwe, and D J Griggs. 2000. Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 44:3118-3121.
28. Preet, S, and P. Rishi. 2010. Antimicrobial activity of Paneth-cell derived cryptdin-2 against selected pathogens. Am. J. Biomed. Sci. 2:13-22.
29. Preet, S., I. Verma, and P. Rishi. 2010. Cryptdin-2: A novel therapeutic agent for experimental Salmonella typhimurium infection. J. Antimicrob. Chemother. 65:991-994.
30. Rishi, P., et al. 2006. Are the increases in local tumour necrosis factor and lipid peroxidation observed in pre-starved mice infected with Salmonella typhimurium markers of increased liver damage? Microbes Infect. 8:1695-1701. (Pubitemid 44128891)
31. Scott, M G, and R E W Hancock. 2000. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit. Rev. Immunol. 20:407-431. (Pubitemid 32106684)
32. Shin, S Y, et al. 2002. Salt resistance and synergistic effect with vancomycin of alpha-helical antimicrobial peptide P18. Biochem. Biophys. Res. Commun. 290:558-562. (Pubitemid 34694538)
33. Su, L H, C H Chiu, C. Chu, and J T Ou. 2004. Antimicrobial resistance in nontyphoid Salmonella serotypes: A global challenge. Clin. Infect. Dis. 39:546-551. (Pubitemid 39120932)
34. Suh, Y C 2010. Plasmid-encoded multidrug resistance: A case study of Salmonella and Shigella from enteric diarrhea sources among humans. Biol. Res. 43:141-148.
35. Tanabe, H., A J Ouellette, M J Cocco, and W E Robinson. 2004. Differential effects on human immunodeficiency virus type 1 replication by α-defensins with comparable bactericidal activities. J. Virol. 78:11622-11631. (Pubitemid 39390748)
36. Ulvatne, H., S. Karoliussen, T. Stiberg, O. Rekdal, and J S Svendsen. 2001. Short antibacterial peptides and erythromycin act synergically against Escherichia coli. J. Antimicrob. Chemother. 48:203-208. (Pubitemid 32755280)
37. Vaara, M, and M. Poro. 1996. Group of peptides that act synergistically with hydrophobic antibiotics against Gram-negative enteric bacteria. Antimicrob. Agents Chemother. 40:1801-1805. (Pubitemid 26277796)
38. Welling, M M, et al. 1998. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J. Clin. Invest. 102:1583-1590. (Pubitemid 28492226)
39. Wiesner, J, and A. Vilcinskas. 2010. Antimicrobial peptides: The ancient arm of the human immune system. Virulence 1:440-464.
40. Wills, E D 1966. Mechanisms of lipid peroxide formation in animal tissues. Biochem. J. 99:667-676.
41. Wiradharma, N., et al. 2011. Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents. Biomaterials 32:2204-2212.
42. Yenugu, S, and G. Narmadha. 2010. The human male reproductive tract antimicrobial peptides of the HE2 family exhibit potent synergy with standard antibiotics. J. Pept. Sci. 16:337-341.
43. Zughaier, S M, W M Shafer, and D S Stephens. 2005. Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell. Microbiol. 7:1251-1262. (Pubitemid 41179418)